Computational and Experimental Drug Discovery Targeting the Glycolytic Pathway in Methicillin-Resistant Staphylococcus Aureus
Journal of Medicine and Life Sciences · 2025
DOI: 10.71222/s0kt8x87 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicine and Life Sciences, 2025. Verfasst von Ziyao Liu.
Abstract (Originalsprache)
This dissertation studies the metabolic pathways of methicillin-resistant Staphylococcus aureus (MRSA), focusing on the enzyme MRSaFBA. It highlights the enzyme's potential as a therapeutic target for antibacterial strategies. By employing biophysical techniques including Dynamic Light Scattering (DLS) and Thermal Denaturation Analysis (TDA), the study provides new insights into the structural stability and aggregation behavior of MRSaFBA under various conditions. The research also demonstrates improvements in protein production and purification processes, enhancing the yield and purity of MRSaFBA and enabling more precise biochemical characterization. Furthermore, enzymatic assays confirm the enzyme's sensitivity to environmental factors and inhibitors, underscoring its potential as a drug target. The study also incorporates molecular docking to understand the interaction mechanisms of potential inhibitors, laying a foundation for the development of MRSaFBA-HCA site.
Zitieren
APA
Liu, Z. (2025). Computational and Experimental Drug Discovery Targeting the Glycolytic Pathway in Methicillin-Resistant Staphylococcus Aureus. Journal of Medicine and Life Sciences. https://doi.org/10.71222/s0kt8x87
Vancouver
Liu Z. Computational and Experimental Drug Discovery Targeting the Glycolytic Pathway in Methicillin-Resistant Staphylococcus Aureus. Journal of Medicine and Life Sciences. 2025. doi:10.71222/s0kt8x87
BibTeX
@article{Liu2025,
author = {Liu, Ziyao},
title = {Computational and Experimental Drug Discovery Targeting the Glycolytic Pathway in Methicillin-Resistant Staphylococcus Aureus},
journal = {Journal of Medicine and Life Sciences},
year = {2025},
doi = {10.71222/s0kt8x87}
}
EUVIMED